Relationship between time of administration, dose, and prophylactic activity of pyrimethamine on sporozoite-induced Plasmodium gallinaceum infections.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D003141:Communicable Diseases; D008288:Malaria; D010964:Plasmodium gallinaceum; D011739:Pyrimethamine; D034101:Sporozoites
D000962:Antimalarials; D011739:Pyrimethamine
ANTIMALARIALS/effects; MALARIA/experimental